Advanced Search

Oncology & Hematology Coding Alert

Clarification:

Pegfilgrastim and Filgrastim

Published on Fri Oct 08, 2004

In the October 2004 Oncology Coding Alert, the article "News You Can Use: How to Make the Best of CMS' Oncology Pay Cuts" on page 77 stated:

"Physicians use pegfilgrastim and filgrastim to increase the number of a patient's white blood cells.
 
"Heads-up: You should report the physician's administration of these drugs using nonchemo codes 90780 (Intravenous infusion for therapy/diagnosis, administered by physician or under direct supervision of physician; up to one hour) and +90781 (... each additional hour ...)."

The last part of the sentence should read, "You should report the physician's administration of these drugs using the appropriate injection code, such as 90782 (Therapeutic, prophylactic or diagnostic injection [specify material injected]; subcutaneous or intramuscular)."
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All